Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

331
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
331
Bioavailability: Overview01:17

Bioavailability: Overview

350
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
350
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

290
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
290
Polyprotic Acids03:38

Polyprotic Acids

31.7K
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
31.7K
Bioavailability: Overview01:13

Bioavailability: Overview

4.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.1K
Factors Influencing Bioavailability: First-Pass Elimination01:23

Factors Influencing Bioavailability: First-Pass Elimination

7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome.

Neurogastroenterology and motility·2015
Same author

A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research.

Neurogastroenterology and motility·2014
Same author

Technical report: an ePRO patient reported outcome program for the evaluation of patients with irritable bowel syndrome.

Neurogastroenterology and motility·2013
Same author

Newcastle disease virus in little owls (Athene noctua) and African penguins (Spheniscus demersus) in an Israeli zoo.

Transboundary and emerging diseases·2013
Same author

Cooling and freezing of epididymal sperm in the common hippopotamus (Hippopotamus amphibius).

Theriogenology·2010
Same author

Epitheliotropic cutaneous lymphoma (mycosis fungoides) in a coati.

The Journal of small animal practice·2007

相关实验视频

汁中的 Askorbic 酸的生物利用性

I Horowitz, E M Fabry, C D Gerson

    JAMA
    |June 14, 1976
    PubMed
    概括

    消毒显著增加汁中非活性 Askorbic 酸,同时减少活性形式. 这影响了营养的生物可用性,突出了加工果汁质量的变化.

    科学领域:

    • 营养生物化学 营养生物化学
    • 食品科学与技术 食品科学与技术
    • 分析化学 分析化学

    背景情况:

    • 亚酸 (维生素C) 对人类健康至关重要,其生物可用性可能会受到食品加工的影响.
    • 汁是酸的常见来源,但像巴氏杀菌这样的加工方法可能会改变其成分.
    • 了解 Askorbic 酸的形式及其在加工饮料中的稳定性对于营养评估至关重要.

    研究的目的:

    • 量化和比较新鲜和巴氏化汁中的生物活性和非活性 Askorbic 酸衍生物.
    • 评估巴氏杀菌对汁中 Askorbic 酸生物可用性的影响.
    • 调查商业制备的汁产品中酸衍生物的变异性.

    主要方法:

    • 在各种汁制剂中分析L-酸,脱-L-酸和2,3-二-L-酸.
    • 使用分析化学技术量化测量活性和非活性 Askorbic 酸形式.
    • 新鲜和巴氏化汁样品之间的比较分析.

    主要成果:

    • 新鲜的汁含有4-7毫克/100毫升的非活性 Askorbic 酸.
    • 与新鲜果汁相比,巴氏化汁呈现出明显更高水平的非活性 Askorbic 酸 (15-30 毫克/100 毫升),增加了多达 400%.

    相关实验视频

  • 新鲜的汁含有高达100%的活性 Askorbic 酸比巴氏杀菌样品,表明加工果汁的生物利用率降低.
  • 结论:

    • 消毒剂显著增加了汁中不活跃的 Askorbic 酸衍生物.
    • 处理导致汁中活性 Askorbic 酸 (维生素 C) 的生物可用性大幅下降.
    • 在不同制成的汁产品中,酸含量和生物可用性存在显著的变化.